Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Total Debt / (EBITDA-CAPEX)

Amag Pharmaceuticals Total Debt / (EBITDA-CAPEX) Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Total Debt / (EBITDA-CAPEX) from 2014 to 2020.
  • Amag Pharmaceuticals Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-7m a 13.33% decrease of -1m year over year
  • Amag Pharmaceuticals Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-4m a 36.50% decrease of -2m year over year
  • Amag Pharmaceuticals Annual Total Debt / (EBITDA-CAPEX) for 2019 was $-3m a 210.51% decrease of -6m from 2018
  • Amag Pharmaceuticals Annual Total Debt / (EBITDA-CAPEX) for 2018 was $3m a -57.66% decrease of -2m from 2017
  • Amag Pharmaceuticals Annual Total Debt / (EBITDA-CAPEX) for 2017 was $5m a 4.95% increase of 0m from 2016
Other Ratios Metrics:
  • Amag Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $27m a -79.63% decrease of -21m year over year
  • Amag Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a -3,223.97% decrease of -46m year over year
  • Amag Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $37m a -153.66% decrease of -56m year over year
View Chart On Koyfin

Quarterly AMAG Total Debt / (EBITDA-CAPEX) Data

06/2020$-7m
03/2020$-5m
12/2019$-2m
09/2019$-6m
06/2019$-2m
03/2019$-2m
12/2018$-4m
09/2018$3m
06/2018$3m
03/2018$6m

Annual AMAG Total Debt / (EBITDA-CAPEX) Data

2019$-3m
2018$3m
2017$5m
2016$4m
2015$5m
2014$33m